Breaking News

French Planes Carry Out First Strikes on Iraq Islamic State Targets
Tweet TWEET

Coming Together for Better Patient Care - Research Report on Air Methods, Express Scripts, Catamaran Corp, Covance and

  Coming Together for Better Patient Care - Research Report on Air Methods,
            Express Scripts, Catamaran Corp, Covance and MedAssets

PR Newswire

NEW YORK, March 6, 2013

NEW YORK, March 6, 2013 /PRNewswire/ --

Today, Investors Alliance announced new research reports highlighting Air
Methods Corporation (NASDAQ: AIRM), Express Scripts Holding Company (NASDAQ:
ESRX), Catamaran Corp (USA) (NASDAQ: CTRX), Covance Inc. (NYSE: CVD) and
MedAssets, Inc. (NASDAQ: MDAS), Today's readers may access these reports free
of charge - including full price targets, industry analysis and analyst
ratings - via the links below.

Air Methods Corporation Research Report

Air Methods now provides medical communication services via its DirectCall
Transfer to KentuckyOne Health's 18 hospitals and ambulatory care centers in
Kentucky. Air Method assists with inter-facility patient transports between
Kentucky One Health-affiliated hospitals and ambulatory care centers and
non-Kentucky One Health medical centers by managing all incoming and outgoing
calls between the health system's hospitals, doctors and other hospitals.
According to Aaron Todd, CEO-Air Methods, the transfer center service won't
just streamline KentuckyOne's patient transfer process but it will also assist
in ensuring that patients remain in their system. The Full Research Report on
Air Methods Corporation - including full detailed breakdown, analyst ratings
and price targets - is available to download free of charge at:
[http://www.investors-alliance.com/r/full_research_report/431f_AIRM]

--

Express Scripts Holding Company Research Report

Express Scripts' SOCRxATES program combines innovative technology with
specially trained community pharmacists. This program plays an important role
in helping patients improve adherence to chronic therapies, as it aims to
improve care for those with chronic medical conditions. The American Journal
of Managed Care reported this program as a success as pharmacists in the
program receiving computer alerts from Express Scripts closed nearly 10% more
adherence-related gaps in care within 30 days compared to pharmacists not
working with the program. It also showed that the same pharmacists were far
more successful in initiating essential therapies. The Full Research Report on
Express Scripts Holding Company - including full detailed breakdown, analyst
ratings and price targets - is available to download free of charge at:
[http://www.investors-alliance.com/r/full_research_report/0ac9_ESRX]

--

Catamaran Corp (USA) Research Report

Catamaran Corporation, a leading provider of pharmacy benefit management
services and technology posts a record setting year with a 100% increase in
revenue on a year-over-year basis. The company's gross profits reached $733.4
million during 2012, compared to $309.5 million in 2011. "This past year has
been a transformative period for Catamaran, led by the merger with Catalyst
which doubled our size. Throughout this period, we never lost sight of our
goals and operational plan, which was the foundation for the results we
achieved in 2012. Our operational excellence, coupled with the successful
progression of our integrations, yielded another record setting year. The
dramatic changes embarked upon by Catamaran in 2012, combined with the
financial savings and clinical results we delivered to our customers, have
created a number of new opportunities for us," said Mark Thierer, Chairman and
CEO of Catamaran. "The entire company is focused on continuing to deliver
superior results, and we are well positioned to take advantage of our growth
and enhanced capabilities in 2013." The Full Research Report on Catamaran Corp
(USA) - including full detailed breakdown, analyst ratings and price targets -
is available to download free of charge at:
[http://www.investors-alliance.com/r/full_research_report/59dd_CTRX]

--

Covance Inc. Research Report

An exclusive alliance and services agreement was sealed between Covance and
M2Gen - a Moffitt Cancer center subsidiary and leader in personalized cancer
treatments. The agreement will promote faster patient recruitment in
biomarker-driven oncology trails by offering to match biopharmaceutical
clients to potential patients. Covance will become M2Gen's preferred provider
for DNA/RNA sequencing, gene expression analysis, and genotyping analysis
services, which will be conducted at Covance's genomic lab in Seattle,
Washington. "Working together, Covance and M2Gen expect to help
biopharmaceutical companies accelerate their drug development programs, make
better decisions, and improve their efforts to develop targeted therapies for
cancer patients," said Ken Somberg, MD, Chief Medical Officer for Covance and
Vice President, Clinical Development Services. "M2Gen's database is unique in
the industry, with clinical data captured and maintained over the cancer
patient's lifetime. This alliance will help us partner with sponsors as the
field of personalized medicine continues to evolve, and as we work toward a
common goal of bringing new life-saving medicines to patients who need them."
The Full Research Report on Covance Inc. - including full detailed breakdown,
analyst ratings and price targets - is available to download free of charge
at: [http://www.investors-alliance.com/r/full_research_report/7945_CVD]

--

MedAssets, Inc. Research Report

Texas' third largest public system, University Health System, has recently
engaged MedAssets for a multi-year, comprehensive agreement for a sustainable,
organizational transformation to eliminate inefficiencies, reduce costs and
enhance revenue and performance to improve the quality and safety of care
delivery. "Anticipating the negative financial impact of healthcare reform,
University Health System was looking for a single, comprehensive source for a
cost-effective suite of data and technology-enabled services to quickly
improve our health system's clinical, operational and financial capabilities,"
said Christann Vasquez, Executive Vice President and CEO, University Health
System. "With MedAssets, we found a true partner to help us meet the new
business model of care delivery. We are excited by the positive change to
date, and we look forward to continue to build upon the progress we have
already accomplished." The multi-pronged agreement is based upon a holistic
operational improvement and cost reduction strategy that focuses on process
and cultural change in five main areas across the enterprise: clinical
resource utilization, labor, purchased services, supply expense and revenue
capture. Specific MedAssets solutions engaged are: Process Improvement and
Clinical Consulting services, Workforce, Capital and Construction solutions,
Strategic Sourcing, Reimbursement Integrity and Charge Integrity solutions.
The Full Research Report on MedAssets, Inc. - including full detailed
breakdown, analyst ratings and price targets - is available to download free
of charge at:
[http://www.investors-alliance.com/r/full_research_report/c110_MDAS]

--

Consider Investors Alliance

Tired of hearing about the latest, greatest trade opportunity... only to
realize that the ship has long sailed? You need a strong, informative
community in your arsenal. Join the group that has been consistently
identifying momentous situations as they develop - long before they become the
next top news on major financial networks.

Contact: Patricia Byers
Email: press@ investors-alliance.com
Main: +1-(408)-745-7826

SOURCE Investors-Alliance
 
Press spacebar to pause and continue. Press esc to stop.